GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltagen Inc (OTCPK:DGEN) » Definitions » Loans Receivable

Deltagen (Deltagen) Loans Receivable : $0.00 Mil (As of Jun. 2007)


View and export this data going back to 2000. Start your Free Trial

What is Deltagen Loans Receivable?

Deltagen's Loans Receivable for the quarter that ended in Jun. 2007 was $0.00 Mil.


Deltagen Loans Receivable Historical Data

The historical data trend for Deltagen's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltagen Loans Receivable Chart

Deltagen Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec05 Dec06
Loans Receivable
Get a 7-Day Free Trial - - - - -

Deltagen Quarterly Data
Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Deltagen Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Deltagen Loans Receivable Related Terms

Thank you for viewing the detailed overview of Deltagen's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltagen (Deltagen) Business Description

Traded in Other Exchanges
N/A
Address
1900 S. Norfolk Street, Suite 105, San Mateo, CA, USA, 94403
Deltagen Inc is a provider of drug discovery tools and services to the biopharmaceutical industry.

Deltagen (Deltagen) Headlines

No Headlines